The microproteome of cancer: from invisibility to relevance

dc.contributor
Institut Català de la Salut
dc.contributor
[Merino-Valverde I, Greco E, Abad M] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Merino Valverde, Iñaki
dc.contributor.author
Greco, Emanuela
dc.contributor.author
Abad Mendez, Maria
dc.date.accessioned
2025-10-25T05:38:48Z
dc.date.available
2025-10-25T05:38:48Z
dc.date.issued
2021-11-11T10:07:18Z
dc.date.issued
2021-11-11T10:07:18Z
dc.date.issued
2020-06-01
dc.identifier
Merino-Valverde I, Greco E, Abad M. The microproteome of cancer: from invisibility to relevance. Exp Cell Res. 2020 Jul 1;392:111997.
dc.identifier
0014-4827
dc.identifier
https://hdl.handle.net/11351/6530
dc.identifier
10.1016/j.yexcr.2020.111997
dc.identifier
32302626
dc.identifier
000535499100001
dc.identifier.uri
http://hdl.handle.net/11351/6530
dc.description.abstract
Càncer; Micropèptid; Supressors de tumors
dc.description.abstract
Cáncer; Micropéptido; Supresores de tumores
dc.description.abstract
Cancer; Micropeptide; Tumor suppressors
dc.description.abstract
Recent findings have revealed that many genomic regions previously annotated as non-protein coding actually contain small open reading frames, smaller that 300 bp, that are transcribed and translated into evolutionary conserved microproteins. To date, only a small subset of them have been functionally characterized, but they play key functions in fundamental processes such as DNA repair, RNA processing and metabolism regulation. This emergent field seems to hide a new category of molecular regulators with clinical potential. In this review, we focus on its relevance for cancer. Following Hanahan and Weinberg's classification of the hallmarks of cancer, we provide an overview of those microproteins known to be implicated in cancer or those that, based on their function, are likely to play a role in cancer. The resulting picture is that while we are at the very early times of this field, it holds the promise to provide crucial information to understand cancer biology.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier
dc.relation
Experimental Cell Research;392
dc.relation
https://doi.org/10.1016/j.yexcr.2020.111997
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Scientia
dc.subject
Càncer
dc.subject
Proteòmica
dc.subject
CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Neoplasm Proteins
dc.subject
Other subheadings::Other subheadings::/physiology
dc.subject
DISEASES::Neoplasms
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas de neoplasias
dc.subject
Otros calificadores::Otros calificadores::/fisiología
dc.subject
ENFERMEDADES::neoplasias
dc.title
The microproteome of cancer: from invisibility to relevance
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)